Teladoc Health, Inc. (NYSE:TDOC) Forecasted to Earn Q2 2021 Earnings of ($0.42) Per Share


Share on StockTwits

Teladoc Health, Inc. (NYSE:TDOC) – Research analysts at Oppenheimer decreased their Q2 2021 earnings per share (EPS) estimates for shares of Teladoc Health in a note issued to investors on Wednesday, April 28th. Oppenheimer analyst M. Wiederhorn now anticipates that the health services provider will post earnings of ($0.42) per share for the quarter, down from their prior forecast of ($0.10). Oppenheimer also issued estimates for Teladoc Health’s Q3 2021 earnings at ($0.37) EPS, Q4 2021 earnings at ($0.33) EPS, FY2021 earnings at ($2.42) EPS, Q1 2022 earnings at ($0.28) EPS, Q2 2022 earnings at ($0.25) EPS, Q3 2022 earnings at ($0.17) EPS, Q4 2022 earnings at ($0.14) EPS and FY2022 earnings at ($0.82) EPS.

A number of other research analysts have also weighed in on TDOC. Zacks Investment Research raised shares of Teladoc Health from a “sell” rating to a “hold” rating and set a $191.00 target price for the company in a research report on Thursday, April 1st. DA Davidson upped their price objective on shares of Teladoc Health from $260.00 to $275.00 and gave the company a “buy” rating in a research report on Wednesday, March 3rd. SVB Leerink upped their price objective on shares of Teladoc Health from $256.00 to $266.00 and gave the company an “outperform” rating in a research report on Wednesday, March 3rd. Craig Hallum cut their price objective on shares of Teladoc Health from $220.00 to $202.00 and set a “hold” rating for the company in a research report on Thursday, April 29th. Finally, Stifel Nicolaus cut their price objective on shares of Teladoc Health from $270.00 to $234.00 in a research report on Thursday, February 25th. Twelve equities research analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the company’s stock. Teladoc Health presently has a consensus rating of “Buy” and an average price target of $241.84.

Teladoc Health stock opened at $158.37 on Monday. The firm has a market cap of $24.43 billion, a price-to-earnings ratio of -110.75 and a beta of 0.30. The company has a debt-to-equity ratio of 0.43, a current ratio of 6.52 and a quick ratio of 6.47. Teladoc Health has a fifty-two week low of $147.71 and a fifty-two week high of $308.00. The firm has a fifty day moving average price of $183.41 and a two-hundred day moving average price of $211.76.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, April 28th. The health services provider reported $0.13 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.57) by $0.70. The firm had revenue of $453.68 million during the quarter, compared to analyst estimates of $452.12 million. Teladoc Health had a negative net margin of 12.71% and a negative return on equity of 6.15%. The business’s revenue was up 150.9% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.40) EPS.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Ford Financial Group LLC grew its stake in shares of Teladoc Health by 8.3% during the first quarter. Ford Financial Group LLC now owns 6,943 shares of the health services provider’s stock valued at $1,261,000 after purchasing an additional 530 shares during the last quarter. Griffin Asset Management Inc. grew its stake in shares of Teladoc Health by 20.8% during the first quarter. Griffin Asset Management Inc. now owns 19,829 shares of the health services provider’s stock valued at $3,604,000 after purchasing an additional 3,412 shares during the last quarter. Oak Ridge Investments LLC grew its stake in shares of Teladoc Health by 963.0% during the first quarter. Oak Ridge Investments LLC now owns 36,375 shares of the health services provider’s stock valued at $6,611,000 after purchasing an additional 32,953 shares during the last quarter. Institute for Wealth Management LLC. grew its stake in shares of Teladoc Health by 8.3% during the first quarter. Institute for Wealth Management LLC. now owns 1,935 shares of the health services provider’s stock valued at $352,000 after purchasing an additional 149 shares during the last quarter. Finally, Commonwealth Equity Services LLC grew its stake in shares of Teladoc Health by 0.4% during the first quarter. Commonwealth Equity Services LLC now owns 108,463 shares of the health services provider’s stock valued at $19,713,000 after purchasing an additional 481 shares during the last quarter. 51.77% of the stock is currently owned by institutional investors and hedge funds.

In other Teladoc Health news, CEO Jason N. Gorevic sold 20,220 shares of the company’s stock in a transaction dated Friday, March 5th. The shares were sold at an average price of $183.18, for a total transaction of $3,703,899.60. Following the sale, the chief executive officer now directly owns 548,296 shares of the company’s stock, valued at $100,436,861.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Arnnon Geshuri sold 350 shares of the company’s stock in a transaction dated Tuesday, March 16th. The stock was sold at an average price of $205.00, for a total transaction of $71,750.00. Following the sale, the insider now directly owns 97,267 shares in the company, valued at $19,939,735. The disclosure for this sale can be found here. Insiders have sold 501,572 shares of company stock worth $94,782,553 over the last ninety days. Insiders own 3.42% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure.

Featured Article: What is Cost of Debt?

Earnings History and Estimates for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.